Hunter Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 711842|Published date: 21 November, 2024
Human Papillomavirus (HPV) Associated Disorders Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 268146|Published date: 21 November, 2024
Human Papillomavirus (HPV) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 769135|Published date: 21 November, 2024
Human Immunodeficiency Virus Type-1 (HIV-1) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 872776|Published date: 21 November, 2024
Homocystinuria Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 991269|Published date: 21 November, 2024
Hodgkin’s Lymphoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 326152|Published date: 21 November, 2024
Hidradenitis Suppurativa Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 316192|Published date: 21 November, 2024
Herpes Zoster Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 725684|Published date: 21 November, 2024
HER2 Negative Breast Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 471150|Published date: 21 November, 2024
HER2+ Gastric Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 786009|Published date: 21 November, 2024
Hepatitis C Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 116127|Published date: 21 November, 2024
Hepatitis B Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 943878|Published date: 21 November, 2024